Mar Carrión
Impact in
- Rheumatology top 5%
- Osteoarthritis Treatment and Mechanisms
- Rheumatoid Arthritis Research and Therapies
-
- Neuropeptides and Animal Physiology
Papers in
- Rheumatology 12
- Osteoarthritis Treatment and Mechanisms 7
- Rheumatoid Arthritis Research and Therapies 4
-
- Neuropeptides and Animal Physiology 13
- Co-authors
- Rosa P. GomarizYasmina JuarranzIrene Gutiérrez‐CañasSelene Pérez‐GarcíaCarmen MartínezJosé L. PablosIsidoro González‐ÁlvaroRebeca Jimeno
In The Last Decade
Mar Carrión
30 papers receiving 794 citations
Peers
Comparison fields: 5 of 83
- Rheumatology 270
- Cellular and Molecular Neuroscience 210
- Immunology 236
- Oncology 191
- Immunology and Allergy 41
Countries citing papers authored by Mar Carrión
This map shows the geographic impact of Mar Carrión's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mar Carrión with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mar Carrión more than expected).
Fields of papers citing papers by Mar Carrión
This network shows the impact of papers produced by Mar Carrión. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mar Carrión. The network helps show where Mar Carrión may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mar Carrión, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2022 | 1 | |
| 3 | 2020 | 9 | |
| 4 | 2020 | 5 | |
| 5 | 2019 | 77 | |
| 6 | 2019 | 13 | |
| 7 | 2019 | 16 | |
| 8 | 2019 | 58 | |
| 9 | 2016 | 27 | |
| 10 | 2014 | 20 | |
| 11 | 2014 | 33 | |
| 12 | 2013 | 23 | |
| 13 | 2013 | 20 | |
| 14 | 2013 | 63 | |
| 15 | 2013 | 13 | |
| 16 | 2011 | 59 | |
| 17 | 2011 | 17 | |
| 18 | 2010 | 38 | |
| 19 | 2008 | 61 | |
| 20 | 2007 | 39 |
About Mar Carrión
Mar Carrión is a scholar working on Rheumatology, Cellular and Molecular Neuroscience, Oncology, Immunology and Allergy and Pharmacology, having authored 30 papers that have together received 803 indexed citations. Recurring topics across this work include Neuropeptides and Animal Physiology (13 papers), Osteoarthritis Treatment and Mechanisms (7 papers), Peptidase Inhibition and Analysis (7 papers), Inflammatory mediators and NSAID effects (7 papers), Chemokine receptors and signaling (4 papers), Asthma and respiratory diseases (4 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and Cancer, Stress, Anesthesia, and Immune Response (3 papers). The work is most often cited by research in Rheumatology (270 citations), Cellular and Molecular Neuroscience (210 citations), Immunology (236 citations), Oncology (191 citations) and Immunology and Allergy (41 citations). Mar Carrión has collaborated with scholars based in Spain, Greece and Germany. Frequent co-authors include Rosa P. Gomariz, Yasmina Juarranz, Irene Gutiérrez‐Cañas, Selene Pérez‐García, Carmen Martínez, José L. Pablos, Isidoro González‐Álvaro, Rebeca Jimeno, Javier Leceta and Alicia Arranz. Their work appears in journals such as International Journal of Molecular Sciences, Journal of Molecular Neuroscience, Scientific Reports, Annals of the Rheumatic Diseases and Cells.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.